NCT01867411View on ClinicalTrials.gov

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

CompletedOBSERVATIONAL

Enrollment

159

Participants

Timeline

Start Date

November 6, 2013

Primary Completion Date

June 29, 2024

Conditions

Nicotine Dependence

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01867411 - Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity | Biotech Hunter | Biotech Hunter